Search
Search
Close this search box.
Search
Close this search box.

Bladder Cancer

Valsartan Lawsuit MDL: Latest Updates on Cancer-Related Claims

Product Liability / July 24, 2024 / 4 minutes of reading / By / , , , , , , , , , , , , , , , , , , , ,

Lawsuits over the alleged link between valsartan and cancer have raised serious concerns about the safety of this widely prescribed blood pressure medication. Reports of contamination with N-nitrosodimethylamine (NDMA), a potential carcinogen, have led to widespread recalls and a surge in legal claims. Patients who relied on valsartan, an angiotensin II receptor blocker (ARB), now […]

Valsartan Lawsuit MDL: Latest Updates on Cancer-Related Claims Read More »

Settlement Nearing for Valsartan Plaintiffs Suing Hetero, But Fight Continues Against Other Manufacturers

Product Liability / June 24, 2024 / 3 minutes of reading / By / , , , , , , , , , , , , , , , , ,

In a notable development in the ongoing valsartan litigation, lawyers are nearing a settlement agreement for those who sued Hetero, a manufacturer of the generic blood pressure medication that was tainted with carcinogenic impurities. This settlement, overseen by U.S. District Court Judge Renée M. Bumb in New Jersey, aims to provide relief to a subset

Settlement Nearing for Valsartan Plaintiffs Suing Hetero, But Fight Continues Against Other Manufacturers Read More »

Valsartan Litigation Update: Hetero Settles Personal Injury and Economic Loss Claims

Product Liability / June 13, 2024 / 4 minutes of reading / By / , , , , , , , , , , , , , , , , , ,

One of the key players involved in the ongoing valsartan NDMA litigation has agreed to a settlement of valsartan lawsuits, providing some relief to individuals impacted by the contaminated blood pressure medication. The U.S. District Judge presiding over the valsartan lawsuits has been informed that a preliminary settlement agreement has been reached with Hetero Drugs,

Valsartan Litigation Update: Hetero Settles Personal Injury and Economic Loss Claims Read More »

First Valsartan NDMA Cancer Lawsuit Cleared to Proceed to Trial

Product Liability / April 12, 2024 / 4 minutes of reading / By / , , , , , , , , , , , , , , ,

More than five years after the initial valsartan recalls, the U.S. District Judge overseeing the valsartan litigation has greenlit the first trial against manufacturers and distributors of the tainted generic blood pressure drug. Over 1,200 valsartan lawsuits have been filed, with individuals alleging that changes to the manufacturing process resulted in the distribution of valsartan

First Valsartan NDMA Cancer Lawsuit Cleared to Proceed to Trial Read More »

Valsartan

Product Liability / April 12, 2024 / 11 minutes of reading / By / , , , , , , , , , , , , ,

Did You Develop Cancer After Taking Valsartan? Valsartan, a commonly prescribed blood pressure medication, has been associated with potential side effects such as an increased risk of cancer, including liver, kidney, and digestive tract cancers, due to the presence of NDMA and other cancer-causing impurities in some batches of the drug. Start My Valsartan Cancer

Valsartan Read More »

Zantac Cancer Lawsuit: Settlement Reached in 4,000 Claims Involving Recalled Heartburn Drug

Product Liability / April 8, 2024 / 4 minutes of reading / By / , , , , , , , , , , , , , ,

Sanofi, the pharmaceutical company behind Zantac (ranitidine), has recently announced a significant settlement agreement to resolve approximately 4,000 cancer lawsuits filed in state courts across the United States. Although this settlement marks a step towards resolution, Sanofi still faces tens of thousands of pending claims related to the recalled heartburn drug, the majority of them

Zantac Cancer Lawsuit: Settlement Reached in 4,000 Claims Involving Recalled Heartburn Drug Read More »

Firefighter Foam

Product Liability / January 29, 2024 / 16 minutes of reading / By / , , , , , , , , , ,

Did You Suffer Cancer from Exposure to Firefighter Foam? Firefighters, U.S. military servicemembers, airport workers and others exposed to dangerous chemicals in firefighter foams or aqueous film forming foam (AFFF) solutions may face an increased risk of thyroid disease and testicular, kidney and bladder cancers caused by the accumulation of the toxic chemicals in the

Firefighter Foam Read More »

Camp Lejeune

Personal Injury / October 4, 2023 / 13 minutes of reading / By / , , , , , , , , , , , ,

Did You Develop Cancer from the Water at Camp Lejeune? A new law makes it easier for victims exposed to contaminated water at Marine Corps Base Camp Lejeune to sue the U.S. government for illnesses and injuries they have suffered, including cancer, birth defects, Parkinson’s disease, and wrongful death. Start My Camp Lejeune Claim Now

Camp Lejeune Read More »

Actos Bladder Cancer Award

Personal Injury / September 19, 2023 / 3 minutes of reading / By / , , , , , ,

Jury Delivers $155K Verdict in Actos Bladder Cancer Suit, Finds Takeda Destroyed Evidence A product liability lawsuit filed over bladder cancer side effects of Actos results in yet another plaintiff win. A West Virginia jury has awarded a retired bakery worker $155,000 in an Actos bladder cancer lawsuit, finding that the maker of the controversial

Actos Bladder Cancer Award Read More »

Actos Bladder Cancer Award

Personal Injury / September 19, 2023 / 3 minutes of reading / By / , , , , , , ,

$2 Million Awarded by Jury in Actos Bladder Cancer Lawsuit A woman who required multiple surgeries to have her bladder cancer removed has been awarded more than $2 million for her Actos injuries and medical bills. A Philadelphia jury last week awarded more than $2 million to a woman who was diagnosed with bladder cancer

Actos Bladder Cancer Award Read More »

Scroll to Top